NANS 2021: Nevro’s HF10 Spinal-Cord Stimulator Succeeds In Two Trials

 
• By Reed Miller

SENZA PDN showed Nevro's HF10 spinal cord stimulation therapy provided sustained relief to patients with painful diabetic neuropathy. Results of a separate trial showed HF10 improved outcomes in patients with non-surgical refractory back pain.

Spinal cord nerve energy impulses into brain
• Source: shutterstock.com

More from Clinical Trials

More from R&D